RY 169.51 -1.1719% SHOP 175.85 -3.2036% TD 85.4 -0.187% ENB 59.6 -1.715% BN 84.78 -1.4873% TRI 250.65 2.1186% CNQ 43.69 0.9007% CP 110.72 -0.5926% CNR 146.88 0.7891% BMO 142.84 -0.6054% BNS 72.34 -0.0829% CSU 4896.4902 0.1981% CM 87.07 -0.9668% MFC 45.08 6.5217% ATD 71.13 -0.6425% NGT 68.13 0.9932% TRP 64.42 -1.2872% SU 56.73 -0.0176% WCN 266.69 -0.146% L 176.74 -1.5157%
Last update at 2025-02-20T19:16:00Z
Here’s Why Baron Health Care Fund Re-established its Position in HealthEquity (HQY)
Wed 19 Feb 25, 03:41 PMHealthEquity Reports Year-End Sales Metrics
Tue 18 Feb 25, 09:01 PMInvesting in HealthEquity (NASDAQ:HQY) three years ago would have delivered you a 94% gain
Sun 09 Feb 25, 01:32 PMDow Jones Leader Caterpillar Eyes Buy Point Ahead Of Earnings
Mon 27 Jan 25, 07:09 PM3 US Stocks That May Be Trading At Discounts Up To 45.9%
Thu 23 Jan 25, 02:02 PMHSA Leader HealthEquity Nears New Buy Point As RS Line Triggers Bullish Signal
Tue 14 Jan 25, 03:38 PMHealthEquity Projects Record Growth for Fiscal Year 2025
Tue 14 Jan 25, 02:33 PMHere's Why You Should Retain HealthEquity Stock in Your Portfolio Now
Fri 10 Jan 25, 12:31 PM| Breakdown | 2023-01-31 | 2022-01-31 | 2021-01-31 | 2020-01-31 | 2019-01-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-01-31 | 2022-01-31 | 2021-01-31 | 2020-01-31 | 2019-01-31 |
| Income before tax | -38.09600M | -66.74100M | 4.14M | 43.16M | 75.82M |
| Minority interest | - | - | - | - | - |
| Net income | -26.14300M | -44.28900M | 8.83M | 39.66M | 73.90M |
| Selling general administrative | 95.63M | 84.38M | 84.49M | 60.56M | 33.04M |
| Selling and marketing expenses | 68.85M | 58.60M | 49.96M | 43.95M | 29.50M |
| Gross profit | 490.09M | 423.71M | 415.33M | 325.91M | 181.19M |
| Reconciled depreciation | 161.20M | 137.19M | 115.90M | 55.35M | 18.18M |
| Ebit | 38.92M | 34.64M | 83.28M | 77.01M | 77.67M |
| Ebitda | 200.12M | 171.82M | 199.18M | 155.39M | 95.86M |
| Depreciation and amortization | 161.20M | 137.19M | 115.90M | 78.38M | 18.18M |
| Non operating income net other | - | - | 5.01M | -9.07900M | -1.85200M |
| Operating income | 38.92M | 34.64M | 83.28M | 77.01M | 77.67M |
| Other operating expenses | 824.10M | 715.99M | 653.57M | 422.88M | 209.57M |
| Interest expense | 48.42M | 36.57M | 34.88M | 24.77M | 0.00000M |
| Tax provision | -11.95300M | -22.45200M | -4.69400M | 3.49M | 1.92M |
| Interest income | 1.76M | 1.50M | 1.04M | 5.91M | - |
| Net interest income | -46.66100M | -36.57200M | -34.88100M | -18.86700M | - |
| Extraordinary items | - | - | - | - | - |
| Non recurring | - | - | 45.99M | 32.11M | - |
| Other items | - | - | - | - | - |
| Income tax expense | -11.95300M | -22.45200M | -4.69400M | 3.49M | 1.92M |
| Total revenue | 861.75M | 756.56M | 733.57M | 531.99M | 287.24M |
| Total operating expenses | 452.44M | 383.14M | 335.33M | 216.79M | 103.52M |
| Cost of revenue | 371.66M | 332.85M | 318.24M | 206.08M | 106.05M |
| Total other income expense net | -77.02000M | -101.37700M | -79.13800M | -33.85100M | -1.85200M |
| Discontinued operations | - | - | - | - | - |
| Net income from continuing ops | -26.14300M | -44.28900M | 8.83M | 39.66M | 73.90M |
| Net income applicable to common shares | -26.14300M | -44.28900M | 8.83M | 39.66M | 73.90M |
| Preferred stock and other adjustments | - | - | - | - | - |
| Breakdown | 2024-01-31 | 2023-01-31 | 2022-01-31 | 2021-01-31 | 2020-01-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2024-01-31 | 2023-01-31 | 2022-01-31 | 2021-01-31 | 2020-01-31 |
| Total assets | 3236.50M | 3088.90M | 3107.10M | 2710.01M | 2565.18M |
| Intangible assets | 835.95M | 936.36M | 973.14M | 767.00M | 783.28M |
| Earning assets | - | - | - | - | - |
| Other current assets | 48.56M | 31.79M | 38.49M | 58.61M | 33.79M |
| Total liab | 1201.48M | 1193.26M | 1254.53M | 1331.28M | 1534.89M |
| Total stockholder equity | 2035.02M | 1895.64M | 1852.58M | 1378.73M | 1030.30M |
| Deferred long term liab | - | - | 4.40M | 5.00M | 6.40M |
| Other current liab | 95.65M | 89.50M | 104.72M | 126.15M | 96.69M |
| Common stock | 0.00900M | 0.00800M | 0.00800M | 0.00800M | 0.00700M |
| Capital stock | 0.00900M | 0.00800M | 0.00800M | 0.00800M | 0.00700M |
| Retained earnings | 205.63M | 149.92M | 176.06M | 220.35M | 211.51M |
| Other liab | - | 95.37M | 114.03M | 128.54M | 133.12M |
| Good will | 1648.14M | 1648.14M | 1645.84M | 1326.79M | 1334.13M |
| Other assets | 0.00000M | 52.18M | 49.81M | 37.42M | 35.11M |
| Cash | 403.98M | 254.27M | 225.41M | 328.80M | 191.73M |
| Cash and equivalents | - | - | - | - | - |
| Total current liabilities | 117.09M | 131.06M | 153.19M | 204.30M | 152.14M |
| Current deferred revenue | - | - | - | - | - |
| Net debt | 529.16M | 740.22M | 782.82M | 746.17M | 1109.37M |
| Short term debt | 9.40M | 27.66M | 20.92M | 76.54M | 51.46M |
| Short long term debt | - | 17.50M | 8.75M | 62.50M | 39.06M |
| Short long term debt total | 933.14M | 994.49M | 1008.23M | 1074.98M | 1301.10M |
| Other stockholder equity | 1829.38M | 1745.72M | 1676.51M | 1158.37M | 818.77M |
| Property plant equipment | - | 69.32M | 86.98M | 118.61M | 33.49M |
| Total current assets | 557.44M | 382.89M | 351.34M | 460.18M | 296.00M |
| Long term investments | - | - | - | - | - |
| Net tangible assets | - | -688.86400M | -766.39800M | -715.06800M | -1085.61500M |
| Short term investments | - | - | - | - | - |
| Net receivables | 104.89M | 96.83M | 87.43M | 72.77M | 70.48M |
| Long term debt | 874.97M | 907.84M | 922.08M | 924.22M | 1181.62M |
| Inventory | - | - | - | - | - |
| Accounts payable | 12.04M | 13.90M | 27.54M | 1.61M | 3.98M |
| Total permanent equity | - | - | - | - | - |
| Noncontrolling interest in consolidated entity | - | - | - | - | - |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
| Accumulated other comprehensive income | 0.00000M | - | - | - | -15.75700M |
| Additional paid in capital | - | - | - | - | - |
| Common stock total equity | - | - | - | 0.00800M | 0.00700M |
| Preferred stock total equity | - | - | - | - | - |
| Retained earnings total equity | - | - | - | 220.35M | 211.51M |
| Treasury stock | - | - | - | - | - |
| Accumulated amortization | - | - | - | - | - |
| Non currrent assets other | -768.08000M | 52.18M | 49.81M | 37.42M | 35.09M |
| Deferred long term asset charges | - | - | - | - | - |
| Non current assets total | 2679.06M | 2706.01M | 2755.76M | 2249.83M | 2269.18M |
| Capital lease obligations | 58.17M | 69.15M | 77.40M | 88.26M | 80.42M |
| Long term debt total | - | - | - | - | 1181.62M |
| Breakdown | 2023-01-31 | 2022-01-31 | 2021-01-31 | 2020-01-31 | 2019-01-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-01-31 | 2022-01-31 | 2021-01-31 | 2020-01-31 | 2019-01-31 |
| Investments | -119.12700M | 2.37M | -96.96400M | -53.84500M | 40.69M |
| Change to liabilities | -26.67300M | -2.17800M | 30.42M | 6.47M | 8.33M |
| Total cashflows from investing activities | -119.12700M | -639.24700M | -96.96400M | -1740.49400M | 25.65M |
| Net borrowings | -8.75000M | -53.12500M | -239.06300M | 1211.68M | 1242.19M |
| Total cash from financing activities | -2.67100M | 394.86M | 52.42M | 1467.74M | 22.93M |
| Change to operating activities | 2.87M | 15.01M | -17.71400M | -1.51600M | 2.14M |
| Net income | -26.14300M | -44.28900M | 8.83M | 39.66M | 73.90M |
| Change in cash | 28.85M | -103.38900M | 137.08M | -169.74900M | 162.00M |
| Begin period cash flow | 225.41M | 328.80M | 191.73M | 361.48M | 199.47M |
| End period cash flow | 254.27M | 225.41M | 328.80M | 191.73M | 361.48M |
| Total cash from operating activities | 150.65M | 141.00M | 181.62M | 105.86M | 113.42M |
| Issuance of capital stock | 0.00000M | 456.64M | 286.78M | 458.50M | - |
| Depreciation | 161.20M | 137.19M | 115.90M | 55.35M | 18.18M |
| Other cashflows from investing activities | - | - | -83.87100M | -1679.36300M | -11.17300M |
| Dividends paid | - | - | - | - | - |
| Change to inventory | - | - | -30.42200M | -4.10100M | -2.28900M |
| Change to account receivables | -9.57000M | -11.20400M | -0.41300M | -6.12700M | -4.30600M |
| Sale purchase of stock | - | - | 295.35M | 469.84M | 22.93M |
| Other cashflows from financing activities | -0.60300M | 941.35M | 4.71M | 1017.06M | 22.93M |
| Change to netincome | 45.70M | 42.02M | 39.48M | 20.36M | 21.70M |
| Capital expenditures | 119.13M | 137.08M | 96.96M | 42.07M | 15.04M |
| Change receivables | - | - | -0.41300M | -5.00900M | -4.30600M |
| Cash flows other operating | - | - | -18.48500M | -11.82500M | -5.32000M |
| Exchange rate changes | - | - | - | - | - |
| Cash and cash equivalents changes | - | - | 137.08M | -169.74900M | 162.00M |
| Change in working capital | -33.37000M | 1.62M | 12.29M | -9.51700M | -1.30000M |
| Stock based compensation | 62.61M | 52.75M | 42.86M | 39.84M | 21.06M |
| Other non cash items | 3.53M | 17.15M | 6.86M | -23.15100M | 1.17M |
| Free cash flow | 31.52M | 3.91M | 84.66M | 63.78M | 98.38M |
Sector: Healthcare Industry: Health Information Services
| Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| HQY HealthEquity Inc |
-1.83 1.61% | 111.95 | 123.86 | 42.37 | 6.88 | 3.38 | 7.41 | 26.13 |
| GEHC GE HealthCare Technologies Inc. |
-0.57 0.62% | 91.95 | 22.91 | 20.12 | 2.01 | 5.52 | 2.39 | 13.30 |
| VEEV Veeva Systems Inc Class A |
-0.64 0.28% | 228.55 | 54.61 | 33.22 | 12.83 | 6.73 | 11.14 | 58.84 |
| MTHRF M3 Inc |
- -% | 9.45 | 29.72 | 25.00 | 0.05 | 4.38 | 0.04 | 0.12 |
| MTHRY M3 Inc |
0.29 4.68% | 6.48 | 31.84 | 26.25 | 0.05 | 4.60 | 0.04 | 0.12 |
HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers flexible spending accounts; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves clients through a direct sales force; benefits brokers and advisors; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. HealthEquity, Inc. was incorporated in 2002 and is based in Draper, Utah.
15 West Scenic Pointe Drive, Draper, UT, United States, 84020
| Name | Title | Year Born |
|---|---|---|
| Mr. Jon Kessler | Pres, CEO & Director | 1968 |
| Mr. Tyson Murdock | Exec. VP & CFO | 1971 |
| Mr. Darcy G. Mott | Special Advisor | 1953 |
| Mr. Larry L. Trittschuh | Exec. VP & Chief Security Officer | 1972 |
| Mr. Elimelech Rosner | Exec. VP & CTO | 1957 |
| Mr. Richard Putnam | VP of Investor Relations | NA |
| Mr. Delano Ladd | Exec. VP, Gen. Counsel & Sec. | 1981 |
| Mr. Steve Lindsay | Exec. VP of Sales & Relationship Management | NA |
| Mr. Brad Bennion | Sr. VP of Corp. Devel. | NA |
| Ms. Tia Padia | Sr. VP of Marketing | NA |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
CA 
AU
UK
US
NZ
Please wait processing your request...